Noninvasive assessment and quantification of tumor vascularization using [18F]FDG-PET/CT and CE-CT in a tumor model with modifiable angiogenesis—an animal experimental prospective cohort study
Open Access
- 21 June 2019
- journal article
- research article
- Published by Springer Nature in EJNMMI Research
- Vol. 9 (1) , 1-17
Abstract
This study investigated the noninvasive assessment of tumor vascularization with clinical F-18-fluorodeoxyglucose positron emission tomography/computed tomography and contrast-enhanced computed tomography ([18F]FDG-PET/CT and CE-CT) in experimental human xenograft tumors with modifiable vascularization and compared results to histology. Tumor xenografts with modifiable vascularization were established in 71 athymic nude rats by subcutaneous transplantation of human non-small-cell lung cancer (NSCLC) cells. Four different groups were transplanted with two different tumor cell lines (either A549 or H1299) alone or tumors co-transplanted with rat glomerular endothelial (RGE) cells, the latter to increase vascularization. Tumors were assessed noninvasively by [18F]FDG PET/CT and contrast-enhanced CT (CE-CT) using clinical scanners. This was followed by histological examinations evaluating tumor vasculature (CD-31 and intravascular fluorescent beads). In both tumor lines (A549 and H1299), co-transplantation of RGE cells resulted in faster growth rates [maximal tumor diameter of 20 mm after 22 (± 1.2) as compared to 45 (± 1.8) days, p < 0.001], higher microvessel density (MVD) determined histologically after CD-31 staining [171.4 (± 18.9) as compared to 110.8 (± 11) vessels per mm2, p = 0.002], and higher perfusion as indicated by the number of beads [1.3 (± 0.1) as compared to 1.1 (± 0.04) beads per field of view, p = 0.001]. In [18F]FDG-PET/CT, co-transplanted tumors revealed significantly higher standardized uptake values [SUVmax, 2.8 (± 0.2) as compared to 1.1 (± 0.1), p < 0.001] and larger metabolic active volumes [2.4 (± 0.2) as compared to 0.4 (± 0.2) cm3, p < 0.001] than non-co-transplanted tumors. There were significant correlations for vascularization parameters derived from histology and [18F]FDG PET/CT [beads and SUVmax, r = 0.353, p = 0.005; CD-31 and SUVmax, r = 0.294, p = 0.036] as well as between CE-CT and [18F]FDG PET/CT [contrast enhancement and SUVmax, r = 0.63, p < 0.001; vital CT tumor volume and metabolic PET tumor volume, r = 0.919, p < 0.001]. In this study, a human xenograft tumor model with modifiable vascularization implementable for imaging, pharmacological, and radiation therapy studies was successfully established. Both [18F]FDG-PET/CT and CE-CT are capable to detect parameters closely connected to the degree of tumor vascularization, thus they can help to evaluate vascularization in tumors noninvasively. [18F]FDG-PET may be considered for characterization of tumors beyond pure glucose metabolism and have much greater contribution to diagnostics in oncology.Keywords
Funding Information
- Bundesministerium für Forschung, Technologie und Raumfahrt (BMBF-03ZIK042)
- SLUB / TU Dresden (Open Access Publication Funds)
This publication has 71 references indexed in Scilit:
- The use of CT perfusion to determine microvessel density in lung cancer: Comparison with FDG-PET and pathologyChinese Journal of Cancer Research, 2011
- Molecular mechanisms and clinical applications of angiogenesisNature, 2011
- Improvement of Radiation-Mediated Immunosuppression of Human NSCLC Tumour Xenografts in a Nude Rat ModelJournal of Biomedicine and Biotechnology, 2010
- Metabolic Tumor Volume Predicts for Recurrence and Death in Head-and-Neck CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Immunohistochemical Detection of Changes in Tumor HypoxiaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- FDG uptake, a surrogate of tumour hypoxia?European Journal of Nuclear Medicine and Molecular Imaging, 2008
- Judah Folkman, a pioneer in the study of angiogenesisAngiogenesis, 2008
- Warburg revisited: imaging tumour blood flow and metabolismCancer Imaging, 2008
- Tumor microvasculature and microenvironment: Targets for anti-angiogenesis and normalizationMicrovascular Research, 2007
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971